Patrick N. Harter
banner
tnonc-harter-lab.bsky.social
Patrick N. Harter
@tnonc-harter-lab.bsky.social
Neuropathologist
Ludwig-Maximilians-University Munich, Germany

Translational NeuroONCology Group @LMU_Muenchen @LMU_Uniklinikum #glioma #melanoma #brainmetastasis
Looking forward to Maastricht 2025
ecnp2025.nl
May 29, 2025 at 6:02 PM
www.uni-muenster.de/Ejournals/in...

Nice overview of Top Ten Papers in Neurooncology 2024 in #freeneuropathology and proud that our work on Brain metastasis is included! Thanks to all the fantastic collaborators and to #freeneuropathology
View of Neurooncology: 2025 update | Free Neuropathology
www.uni-muenster.de
March 30, 2025 at 8:12 AM
In some aspects it is already 5 past 12 but anyway Never too Late to adjust the clockwork. This is a fantastic Initiative by many great colleagues and Friends! 💪🏽 Thank you!!! Check out aufstehenfuerdemokratie.de
February 8, 2025 at 8:02 AM
Reposted by Patrick N. Harter
Excited to collaborate with @hoheyn.bsky.social, @jcnietos.bsky.social, @paulanietog.bsky.social & team on leptomeningeal metastatic disease - a key challenge in #NeuroOncology. Our study reveals unique immune responses in CSF, highlighting CSF liquid biopsy’s potential to guide CNS tumor therapies.
📢 SUPER EXCITED to share our latest preprint:
Decoding the immune response in leptomeningeal disease through single-cell sequencing of cerebrospinal fluid

Incredible work and collaboration from @jcnietos.bsky.social @piazeiner.bsky.social @hoheyn.bsky.social and others.
biorxiv.org/content/10.110…
https://biorxiv.org/content/10.110…
January 29, 2025 at 12:33 PM
PhD position translational program of clinical study on glioblastoma (experimental/computational) supported by DKH. Lively research community and supervised by Prof. Kristian Unger, AI-Professor at LMU Munich and myself.
Looking forward to your applications !
euraxess.ec.europa.eu/jobs/306276
PhD position translational program of clinical study on glioblastoma (experimental/computational)
The experimental and computational doctoral position (3 years, TV-L E13 65%) is located in the AI-assisted therapy decisions in oncology group (Prof.
euraxess.ec.europa.eu
January 11, 2025 at 8:37 AM
www.nature.com/articles/s41...

Overcoming ICI resistance. Great translation of basic research. Congratulations to all authors and special thanks to Jörg Wischhusen for his dedication to this project!
Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours - Nature
A study reporting the results of a clinical trial co-administering the GDF-15-blocking antibody visugromab with the anti-PD-1 antibody nivolumab demonstrates that neutralizing GDF-15 can overcome resi...
www.nature.com
January 7, 2025 at 10:12 PM